PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis

This network meta-analysis (NMA) evaluates the safety of first-line programmed death-ligand 1 (PD-L1) inhibitor monotherapy in advanced NSCLC patients compared to platinum-based chemotherapy. We also compared the risk of adverse events (AEs) according to programmed cell death-1 receptor (PD-1) or PD...

Descripción completa

Detalles Bibliográficos
Autores principales: García Campelo, María Rosario, Arriola, Edurne, Campos Balea, Begoña, López-Brea, Marta, Fuentes-Pradera, José, de Castro Carpeno, Javier, Aguado, Carlos, Pérez Parente, Diego, de Oro Pulido, Fidel, Ruiz-Gracia, Pedro, Rodríguez-Abreu, Delvys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509645/
https://www.ncbi.nlm.nih.gov/pubmed/34640601
http://dx.doi.org/10.3390/jcm10194583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509645/
https://www.ncbi.nlm.nih.gov/pubmed/34640601
http://dx.doi.org/10.3390/jcm10194583

Ejemplares similares